Correction to: Dutch Economic Value of Radium-223 in Metastatic Castration-Resistant Prostate Cancer

被引:0
|
作者
Michel L. Peters
Claudine de Meijer
Dirk Wyndaele
Walter Noordzij
Annemarie M. Leliveld-Kors
Joan van den Bosch
Pieter H. van den Berg
Agni Baka
Jennifer G. Gaultney
机构
[1] Real World Strategy and Analytics,Department of Nuclear Medicine
[2] Mapi Group,Department of Nuclear Medicine and Molecular Imaging
[3] Bayer B.V.,Department of Urology
[4] Catharina Ziekenhuis,Department of Internal Medicine
[5] University of Groningen,Department of Internal Medicine
[6] University Medical Centre Groningen,undefined
[7] University of Groningen,undefined
[8] University Medical Centre Groningen,undefined
[9] Albert Schweitzer Ziekenhuis,undefined
[10] Tergooi Ziekenhuizen,undefined
[11] Real World Strategy and Analytics,undefined
[12] Mapi Group,undefined
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The article Dutch Economic Value of Radium-223 in Metastatic Castration-Resistant Prostate Cancer, written by Michel L. Peters, Claudine de Meijer, Dirk Wyndaele, Walter Noordzij, Annemarie M. Leliveld-Kors, Joan van den Bosch, Pieter H. van den Berg, Agni Baka, Jennifer G. Gaultney was originally published electronically on the publisher’s internet portal (currently SpringerLink) on 2nd September, 2017 without open access.
引用
收藏
页码:145 / 145
相关论文
共 50 条
  • [41] Acute Promyelocytic Leukemia After Treatment of Metastatic Castration-Resistant Prostate Cancer With Radium-223
    Odo, Ugochukwu
    Vasudevamurthy, Ashwin K.
    Sartor, Oliver
    [J]. CLINICAL GENITOURINARY CANCER, 2017, 15 (03) : E501 - E502
  • [42] Radium-223 in Metastatic Castration-Resistant Prostate Cancer: Clinical Development and Use in Contemporary Practice
    Morgan, Scott C.
    [J]. JOURNAL OF MEDICAL IMAGING AND RADIATION SCIENCES, 2019, 50 (04) : S26 - S30
  • [43] Impact of treatment delay in Radium-223 therapy of metastatic castration-resistant prostate cancer patients
    Marie Øbro Fosbøl
    Peter Meidahl Petersen
    Gedske Daugaard
    Søren Holm
    Andreas Kjaer
    Jann Mortensen
    [J]. Annals of Nuclear Medicine, 2018, 32 : 16 - 21
  • [44] Factors Associated With Survival Following Radium-223 Treatment for Metastatic Castration-resistant Prostate Cancer
    Wong, William W.
    Anderson, Eric M.
    Mohammadi, Homan
    Daniels, Thomas B.
    Schild, Steve E.
    Keole, Sameer R.
    Choo, C. Richard
    Tzou, Katherine S.
    Bryce, Alan H.
    Ho, Thai H.
    Quevedo, Fernando J.
    Vora, Sujay A.
    [J]. CLINICAL GENITOURINARY CANCER, 2017, 15 (06) : E969 - E975
  • [45] Emerging role of Radium-223 in the growing therapeutic armamentarium of metastatic castration-resistant prostate cancer
    Picciotto, Maria
    Franchina, Tindara
    Russo, Alessandro
    Ricciardi, Giuseppina Rosaria Rita
    Provazza, Giusy
    Sava, Serena
    Baldari, Sergio
    Caffo, Orazio
    Adamo, Vincenzo
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (09) : 899 - 908
  • [46] Impact of treatment delay in Radium-223 therapy of metastatic castration-resistant prostate cancer patients
    Fosbol, Marie Obro
    Petersen, Peter Meidahl
    Daugaard, Gedske
    Holm, Soren
    Kjaer, Andreas
    Mortensen, Jann
    [J]. ANNALS OF NUCLEAR MEDICINE, 2018, 32 (01) : 16 - 21
  • [47] Radionuclide Therapies in Prostate Cancer: Integrating Radium-223 in the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer
    Nilsson, Sten
    [J]. CURRENT ONCOLOGY REPORTS, 2016, 18 (02) : 1 - 12
  • [48] Radionuclide Therapies in Prostate Cancer: Integrating Radium-223 in the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer
    Sten Nilsson
    [J]. Current Oncology Reports, 2016, 18
  • [49] Fracture risk in men with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 (Ra 223)
    Hijab, A.
    Tunariu, N.
    Tovey, H.
    Alonzi, R.
    Tree, A.
    Staffurth, J.
    Blackledge, M.
    Padhani, A. R.
    Stidwill, H.
    Finch, J.
    Chatfield, P.
    Perry, S.
    Koh, D-M.
    Hall, E.
    Parker, C.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S539 - S539
  • [50] Radium-223 Chloride A New Treatment Option for Metastatic Castration-Resistant Prostate Carcinoma
    Pinto, Alvaro
    Cruz, Patricia
    [J]. DRUGS IN R&D, 2012, 12 (04) : 227 - 233